Introduction {#sec1-1}
============

Different epidemiological study designs are available and are adopted by a researcher depending on the research question at hand. An observational study is one type of epidemiological study design, which can be in the form of a cohort, a case--control, or a cross-sectional study. This type of study design (observational) is defined as a nonexperimental research, where the researcher observes a particular environmental behavior without artificially controlling the environment under study. To ascertain high-quality reporting of observational studies, the Strengthening the Reporting of Observational studies in Epidemiology (STROBE) guidelines were developed following a collaborative initiative of epidemiologists, methodologists, statisticians, researchers, and journal editors in 2004.\[[@ref1]\] These guidelines were created to aid in the presentation of the conducted observational study to ensure adequate reporting (what was planned, done, found, and concluded) as well as assessment of the strengths and weaknesses of the study.\[[@ref1][@ref2]\] Such study information is of vital importance in a manuscript since this will determine whether the established results can be included in systemic reviews later on.\[[@ref3][@ref4]\] Furthermore, the STROBE guidelines enable the journal\'s editor, reviewers, and the readers to critically appraise the study.\[[@ref1]\]

The STROBE Guidelines {#sec1-2}
=====================

The aim of the STROBE guidelines was to provide a readily available checklist to ensure a clear presentation of what was planned and conducted in an observational study. These studies are set out to investigate the associations between an exposure and a health outcome. In no way were these guidelines established to provide a methodological framework for conducting an observational study.\[[@ref1]\] Nor were the guidelines developed as an instrument for quality evaluation of observational research.\[[@ref2]\] Furthermore, the guidelines were not aimed to bring forward standardization of manuscripts but rather to encourage the production of interesting and narrative articles while maintaining transparency.\[[@ref5]\]

The Strobe Checklist {#sec1-3}
====================

A total of 22 checklist items contribute to the STROBE guidelines. Eighteen items are common to all the three observational designs, that is, cohort, cross-sectional, and case--control studies. However, the remaining four checklist items (items number 6, 12, 14, and 15) have specific variations according to the study design. [Table 1](#T1){ref-type="table"} exhibits the STROBE guidelines as published by Vandenbroucke *et al*.\[[@ref1]\] The following is an abbreviated explanation of the checklist items.

###### 

STROBE guidelines

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  STROBE guidelines                  
  --------------------------- ------ -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Title and abstract          1      Indicate the study's design with a commonly used term in the title or the abstract\
                                     Provide in the abstract an informative and balanced summary of what was done and what was found

  Introduction                       

   Background/rationale       2      Explain the scientific background and rationale for the investigation being reported

   Objectives                 3      State specific objectives, including any prespecified hypotheses

  Methods                            

   Study design               4      Present key elements of study design early in the manuscript

   Setting                    5      Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data collection

   Participants               6      Cohort study - give the eligibility criteria, and the sources and methods of selection of participants; describe methods of follow-up\
                                     Case-control study - give the eligibility criteria, and the sources and methods of case ascertainment and control selection; give the rationale for the choice of cases and controls\
                                     Cross-sectional study - give the eligibility criteria, and the sources and methods of selection of participants\
                                     Cohort study - for matched studies, give matching criteria and number of exposed and unexposed Case-control study - for matched studies, give matching criteria and the number of controls per case

   Variables                  7      Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers; give diagnostic criteria, if applicable

   Data sources/measurement   8\*    For each variable of interest, give sources of data and details of methods of assessment (measurement); describe comparability of assessment methods if there is more than one group

   Bias                       9      Describe any efforts to address potential sources of bias

   Study size                 10     Explain how the study size was arrived at

   Quantitative variables     11     Explain how quantitative variables were handled in the analyses; if applicable, describe which groupings were chosen and why

   Statistical methods        12     Describe all statistical methods, including those used to control for confounding\
                                     Describe any methods used to examine subgroups and interactions\
                                     Explain how missing data were addressed\
                                     Cohort study - if applicable, explain how loss to follow-up was addressed\
                                     Case-control study - if applicable, explain how matching of cases and controls was addressed\
                                     Cross-sectional study - if applicable, describe analytical methods taking account of sampling strategy\
                                     Describe any sensitivity analyses

  Results                            

   Participants               13\*   Report numbers of individuals at each stage of study - e.g., numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analyzed\
                                     Give reasons for nonparticipation at each stage Consider use of a flow diagram

   Descriptive data           14\*   Give characteristics of study participants (e.g., demographic, clinical, social) and information on exposures and potential confounders\
                                     Indicate number of participants with missing data for each variable of interest Cohort study - summarize follow-up time (e.g., average and total amount)

   Outcome data               15\*   Cohort study - report numbers of outcome events or summary measures over time\
                                     Case-control study - report numbers in each exposure category, or summary measures of exposure\
                                     Cross-sectional study - report numbers of outcome events or summary measures

   Main results               16     Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision (e.g., 95% confidence interval); make clear which confounders were adjusted for and why they were included Report category boundaries when continuous variables were categorized\
                                     If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period

   Other analyses             17     Report other analyses done - e.g., analyses of subgroups and interactions, and sensitivity analyses

  Discussion                         

   Key results                18     Summarize key results with reference to study objectives

   Limitations                19     Discuss limitations of the study, taking into account sources of potential bias or imprecision; discuss both direction and magnitude of any potential bias

   Interpretation             20     Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence

   Generalizability           21     Discuss the generalizability (external validity) of the study results

  Other information                  

   Funding                    22     Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*Give information separately for cases and controls in case-control studies and, if applicable, for exposed and unexposed groups in cohort and cross-sectional studies

Item 1: Title and Abstract {#sec1-4}
==========================

The adopted study design should be part of the manuscript title to ensure correct indexing of the manuscript in electronic databases. Indexing of the published manuscript is of utmost importance to ensure visibility of a researcher\'s work and increase the citation potential of the published manuscript. Citation of published manuscripts is imperative for the enhancement of the researcher\'s research metrics and for increasing the prestigious acknowledgement of the researcher and his or her work within the scientific community.\[[@ref6]\] The abstract should include a brief summary of the study and present only information found within the actual body of the manuscript.

Items 2 and 3: Introduction {#sec1-5}
===========================

The introduction should consist of background information that will set the scene for the study and the objective of the study. The objective states the researcher\'s intentions for conducting the study and potential hypotheses that may arise from such work.

Items 4--12: Methods {#sec1-6}
====================

The methods section should provide a clear description of the study design at an early stage. This will enable the reader to understand the basis of the study and be able to critically appraise the study\'s methodology. The STROBE guidelines do not allow the use of the words "prospective" or "retrospective" or "concurrent" or "historical," but rather encourage the researcher to describe the actual methodology.\[[@ref1]\]

Information on the tools of measurement, setting, and locations should be reported to enhance the reader\'s understanding of the study\'s results. The reporting of the participants\' recruitment procedure will vary depending on the type of observation design being conducted. Therefore, it is important that the researcher is knowledgeable about the epidemiological methodological design for each different observational study (i.e., cohort, case--control, or cross-sectional, respectively).

All the variables considered for the descriptive and statistical analysis of the study need to be noted down within the methods section. This also includes the reporting of any specific cut-off points implemented during the analysis. It is essential that any exposures, confounders, or outcomes measurements are accounted for and reported for the reader to critically appraise the study\'s reliability and validity. The inclusion and exclusion criteria and methods to overcome any potential bias should be noted down as well.

The method used to establish the study size needs to be reported along with the confidence intervals considered. This is essential for the reader to ascertain whether sufficient statistical precision has been attained in the study.\[[@ref1]\]

The reporting of statistical analysis will vary depending on the study design (i.e., cohort, case--control, or cross-sectional). However, it is important that all statistical methods and adjustments for potential confounders or missing data are noted down clearly.

Items 13--17: Results {#sec1-7}
=====================

The results section should give an in-depth account of the response rate and the description of the study population along with the main descriptive and analytical results. The information provided will depend on the type of observational design (i.e., cohort, case--control, or cross-sectional) followed by the researcher and the corresponding statistical analysis performed.

Items 18--21: Discussion {#sec1-8}
========================

The discussion should address all the central issues of the study including the validity of the study. The objective/s of the study should be kept in mind while discussing the findings. Comparisons to already published literature are essential. It may be appropriate for the discussion section to be subdivided into different sections to enable better interpretation of the study findings. The researcher should provide an objective assessment of the findings and avoid overinterpretations. Potential confounder effects that might have had an effect on the results and associations obtained in the study should be considered. Therefore, it is imperative to note down potential limitations faced by the study, while noting any bias that might have been present. Furthermore, researchers have to keep in mind that causality of a particular outcome cannot be established in most study designs, unless a longitudinal cohort study has been conducted. Therefore, this fact needs to be acknowledged during the discussion and may act as a study limitation for certain study designs. Study limitations go hand in hand with recommendations for further research to validate the study or further establish associations that were revealed by the study.

Item 22: Funding and Sponsorship {#sec1-9}
================================

The source of funding and the role of the funders in the study are essential pieces of information that are required at the end of the article. This is accompanied with any conflict of interest of both the author/s and the funders.

Conclusion {#sec1-10}
==========

A substantial number of journals are requesting authors to follow the STROBE guidelines before submitting their observational-study-inspired manuscript. Having a thorough understanding of the STROBE guidelines is therefore becoming a requisite for authors who wish to conduct and publish an observational study. These guidelines have been formulated as an aid to authors to enable them to construct an adequately presented manuscript that allows the reader to fully comprehend and critically appraise the manuscript.
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